{
    "id": "dbpedia_920_0",
    "rank": 59,
    "data": {
        "url": "https://www.blueowl.com/our-team",
        "read_more_link": "",
        "language": "en",
        "title": "Blue Owl Capital",
        "top_image": "https://www.blueowl.com/themes/custom/blueowl/favicon.ico",
        "meta_img": "https://www.blueowl.com/themes/custom/blueowl/favicon.ico",
        "images": [
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100107.png?itok=v3mDUat8",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100102.jpg?itok=-0GCSAwx",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100109.png?itok=aq6mLRM_",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/101054.png?itok=G0AfLMKf",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100624.jpg?itok=5vTAk0E_",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100972.png?itok=Pa5NQi7a",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100112.png?itok=w13ATZa6",
            "https://www.blueowl.com/sites/default/files/styles/employee_directory_desktop_2x/public/employee-photos/100612.jpg?itok=aEuXxW1D"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Meet the Blue Owl team, a group of exceptional people who are shaping the future of alternative investments.",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/blueowl/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.blueowl.com/our-team",
        "text": "Frank A. Alleva is a Managing Director at Blue Owl and member of the Tax Team. In his role, he is primarily focused on product structuring, tax compliance, investor reporting and other asset management tax operational matters across the various business strategies.\n\nBefore joining Blue Owl, Frank was a Vice President at Blackstone focused on both the publicly traded company and head of retail funds tax. Prior to that, he was a Tax Manager at PwC in the Real Estate Asset Management practice. Frank began his career at KPMG in the Real Estate and Construction Tax practice.\n\nFrank received a BS in Accounting and a MS in Taxation from St. John’s University, where he graduated magna cum laude. Frank is a licensed Certified Public Accountant in New York.\n\nHaitham Abdulkarim is a Managing Director at Blue Owl and member of the Institutional Business Development Team. In his role, he focuses on capital raising and fund formation in the Middle East, working closely with a variety of internal stakeholders to bring the firm’s investment strategies to the region.\n\nBefore joining Blue Owl, Haitham was a senior member of the Middle East Institutional Client Business team at BlackRock; leading client strategy and engagement for the United Arab Emirates, Oman, and Bahrain. Haitham was previously responsible for promoting BlackRock’s private markets offering to investors in the Kingdom of Saudi Arabia, and helped establish the firm's first fund dedicated to the region.\n\nPrior to that, he led investor relations at Mubadala-backed Waha Capital in Abu Dhabi and at Samena Capital, a pan-Asia private equity firm based out of Dubai. Haitham began his career in Mergers & Acquisitions, with roles at HSBC Global Banking & Markets and BNP Paribas CIB in Dubai and Singapore.\n\nHe received his Bachelor of Arts (Honors) in Finance, Accounting & Management from the University of Nottingham in the United Kingdom.\n\nSandip Agarwala is a Managing Director at Blue Owl and member of the Direct Lending Investment Team. In his role, he focuses on life sciences credit, royalty and growth equity investments.\n\nBefore joining Blue Owl, Sandip was a Managing Director at Longitude Capital, a life sciences focused investment firm. Prior to that, he was a Vice President at Auven Therapeutics Management. Sandip began his career as a management consultant with The Boston Consulting Group and The Frankel Group.\n\nSandip received his MBA in Finance and Healthcare Management from The Wharton School and holds a BSE in Systems Science and Engineering from the University of Pennsylvania.\n\nIlan Aharoni is a Principal at Blue Owl and member of the Direct Lending Investment Team. Based in Menlo Park, he is focused on growth-stage investing in leading technology businesses, primarily across SaaS, Infrastructure, and Security.\n\nBefore joining Blue Owl, Ilan was a Senior Associate at Vector Capital, a technology-focused private equity fund based in San Francisco. Ilan began his career as an Investment Banking Analyst at J.P. Morgan in London and San Francisco.\n\nIlan received a BS in International Business Administration and an MS in Finance and Investments, cum laude, from Rotterdam School of Management – Erasmus University in the Netherlands.\n\nJoe Alongi is a Managing Director at Blue Owl and the Chief Financial Officer, Private Credit Funds. Joe is a member of the firm's Operating Committee as well as the Blue Owl Credit Operating and Valuation Committees.\n\nPrior to joining Blue Owl in 2018, Joe was a Director at Guggenheim Partners Investment Management, where he served as a Controller in the Private Commingled Fund Accounting Group and was responsible for the accounting and reporting for various Alternative Investment Funds and CLOs. Prior to that, Joe worked within the Financial Services practice of PwC where he specialized in audits of alternative investment funds and registered investment companies.\n\nJoe received a BS in Accounting from Villanova University and is a licensed Certified Public Accountant in New York.\n\nKaitlin Alvarez is a Principal at Blue Owl and member of the Investor Operations Team. Based in Short Hills, she focuses on strategic projects and technology initiatives.\n\nBefore joining Blue Owl, Kaitlin was the Senior Manager of Investor Services at Warburg Pincus, a private equity firm based in New York, where she identified enhancements to procedures to improve efficiency and reduce risk.\n\nKaitlin received both her MA and BA in Communication from Marist College.\n\nKerri Amato is a Managing Director at Blue Owl and member of the Compliance Team. Kerri is also the Chief Compliance Officer of Blue Owl Securities LLC, the firm’s limited purpose broker-dealer. In her role as head of compliance distribution, she focuses on Blue Owl’s global expansion, and in her role as CCO of Blue Owl Securities, she is responsible for the broker-dealer’s compliance program. Before joining Blue Owl, Kerri was a Managing Director at AQR Capital Management, LLC and served as the Chief Compliance Officer for AQR Investments, LLC. Kerri began her career as a Marketing Associate then transitioned to the Compliance Team at Arhnold & S. Bleichroeder Advisers LLC.\n\nKerri received her BBA in International Finance and Marketing from the University of Miami and holds a MBA in Finance and Marketing from Baruch College, Zicklin School of Business.\n\nTimothy Anderson is a Managing Director at Blue Owl and member of the Healthcare Opportunities Investment Team. In his role, he focuses on investments in biotechnology, diagnostics, and digital medicine companies and sits on the Fund's Investment Committee.\n\nPreviously Tim was a co-founding member and Managing Director of Cowen Healthcare Investments, the predecessor to Blue Owl Healthcare Opportunities. Prior to his role at Cowen Healthcare Investments, Tim was a biotechnology investment banker at Cowen and Company.\n\nHe is currently a member of the Board of Directors of Lycia Therapeutics, F2G, Anaveon, Autobahn Therapeutics and Scipher Medicine. Tim previously served as a Board Member or Board Observer of Tourmaline Bio, Vectiv Bio Holdings, Therachon, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics.\n\nTim received a BA in both Economics and Government & Legal studies from Bowdoin College.\n\nPete Andreuccetti is a Principal at Blue Owl and member of the Direct Lending Investment Team. Based in New York, he is focused on investments to middle market firms across the capital structure.\n\nBefore joining Blue Owl, Pete was an Associate Director at Macquarie working on infrastructure and real assets credit. Prior to that, he was an Associate at Deutsche Bank in the Commodities Group and based in London.\n\nPete received an MBA from the University of Chicago Booth School of Business and a BS in Chemical Engineering from Northwestern University, where he graduated with honors.\n\nJoanna Antkowiak is a Principal at Blue Owl and member of the Private Wealth Team. In her role, she focuses on the expansion of Blue Owl’s private wealth business across EMEA. She is responsible for establishing and nurturing strategic partnerships with key private banks, designing a strategy on entering new markets, and building the private wealth team across the region.\n\nBefore joining Blue Owl, Joanna spent nearly a decade at Blackstone, most recently as a Vice President in their Private Wealth Solutions team. Prior to that, she began her career as a Researcher at Dealogic in the Institutional Client Management team.\n\nJoanna received her BA in International Business, with high honors, from the University of Westminster. She is a CAIA charterholder."
    }
}